SPOTLIGHT -
Opinion
Video
Author(s):
The Psychiatric Times editor-in-chief shares perspectives on how a novel treatment, MDMA-assisted therapy, can potentially change the treatment landscape and improve patients’ lives.
April in Review: Updates on the Psychiatric Treatment Pipeline
David Hellerstein, MD: Psychedelic Treatments for Psychiatric Disorders
How to Decide Whether Depressions Are Bipolar Depressions
Anne Marie Albano, PhD: A Conversation on the Spectrum of Anxiety
Why Developmental Trauma Disorder Should Be Included in the DSM: A Case Study
What Went Wrong? Top 6 Clinical Disappointments